- About us
- Join Putnam
Putnam PHMR’s client needed a detailed description of multiple myeloma treatment patterns and
resource utilization in Japanese patients.
Using the data source of The Medical Data Vision (MDV) database (2008 – 2015), our RWE and
Biostatistics team worked to:
With our RWE and Biostatistics team’s findings, we came to the solution of generating a retrospective longitudinal observational cohort study exploring the treatment pattern of patients and related- outcomes in patients with multiple myeloma.
An emerging biotech sought Putnam’s guidance to design and execute the global commercialization of their asset for a rare oncology indication.
A global, top-10 pharma client sought Putnam’s guidance on developing a lean launch strategy for a novel cell therapy in oncology.
The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.